Abstracts by key term: long-term economic effects
Economic long-term effects of innovative therapy concepts using the example of hepatitis C
Recently published economic data show that hepatitis C therapy with direct antiviral agents (DAAs) leads to significant long-term savings in direct and indirect healthcare costs due to its curative nature. This example implies that when assessing the efficiency of innovations, it is crucial to weigh up clinical and economic short- and long-term effects in order to optimally use financial resources in the healthcare system.